SC 13G CUMBERLAND PHARMACEUTICALS OCT13

Company

CUMBERLAND PHARMACEUTICALS INC

Filed

November 8, 2013

Accession Number

0000936753-13-000113

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →